These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
285 related articles for article (PubMed ID: 29632081)
41. Effectiveness of a cardiac rehabilitation program on biomechanical, imaging, and physiological biomarkers in elderly patients with heart failure with preserved ejection fraction (HFpEF): FUNNEL + study protocol. Cuesta-Vargas AI; Fuentes-Abolafio IJ; García-Conejo C; Díaz-Balboa E; Trinidad-Fernández M; Gutiérrez-Sánchez D; Escriche-Escuder A; Cobos-Palacios L; López-Sampalo A; Pérez-Ruíz JM; Roldán-Jiménez C; Pérez-Velasco MA; Mora-Robles J; López-Carmona MD; Pérez-Cruzado D; Martín-Martín J; Pérez-Belmonte LM BMC Cardiovasc Disord; 2023 Nov; 23(1):550. PubMed ID: 37950216 [TBL] [Abstract][Full Text] [Related]
42. Rationale and design of the EMPERIAL-Preserved and EMPERIAL-Reduced trials of empagliflozin in patients with chronic heart failure. Abraham WT; Ponikowski P; Brueckmann M; Zeller C; Macesic H; Peil B; Brun M; Ustyugova A; Jamal W; Salsali A; Lindenfeld J; Anker SD; Eur J Heart Fail; 2019 Jul; 21(7):932-942. PubMed ID: 31218819 [TBL] [Abstract][Full Text] [Related]
43. The Effect of Weight Loss Through Lifestyle Interventions in Patients With Heart Failure With Preserved Ejection Fraction-A Systematic Review and Meta-Analysis of Randomised Controlled Trials. Lee VYJ; Houston L; Perkovic A; Barraclough JY; Sweeting A; Yu J; Fletcher RA; Arnott C Heart Lung Circ; 2024 Feb; 33(2):197-208. PubMed ID: 38320881 [TBL] [Abstract][Full Text] [Related]
44. A transcatheter intracardiac shunt device for heart failure with preserved ejection fraction (REDUCE LAP-HF): a multicentre, open-label, single-arm, phase 1 trial. Hasenfuß G; Hayward C; Burkhoff D; Silvestry FE; McKenzie S; Gustafsson F; Malek F; Van der Heyden J; Lang I; Petrie MC; Cleland JG; Leon M; Kaye DM; Lancet; 2016 Mar; 387(10025):1298-304. PubMed ID: 27025436 [TBL] [Abstract][Full Text] [Related]
45. Goal-oriented cognitive rehabilitation for early-stage Alzheimer's and related dementias: the GREAT RCT. Clare L; Kudlicka A; Oyebode JR; Jones RW; Bayer A; Leroi I; Kopelman M; James IA; Culverwell A; Pool J; Brand A; Henderson C; Hoare Z; Knapp M; Morgan-Trimmer S; Burns A; Corbett A; Whitaker R; Woods B Health Technol Assess; 2019 Mar; 23(10):1-242. PubMed ID: 30879470 [TBL] [Abstract][Full Text] [Related]
46. Safety and effectiveness of standardized exercise training in patients with pulmonary hypertension associated with heart failure with preserved ejection fraction (TRAIN-HFpEF-PH): study protocol for a randomized controlled multicenter trial. Palevičiūtė E; Čelutkienė J; Šimbelytė T; Gumbienė L; Jurevičienė E; Zakarkaitė D; Čėsna S; Eichstaedt CA; Benjamin N; Grünig E Trials; 2023 Apr; 24(1):281. PubMed ID: 37072812 [TBL] [Abstract][Full Text] [Related]
47. Effect of endurance exercise training on endothelial function and arterial stiffness in older patients with heart failure and preserved ejection fraction: a randomized, controlled, single-blind trial. Kitzman DW; Brubaker PH; Herrington DM; Morgan TM; Stewart KP; Hundley WG; Abdelhamed A; Haykowsky MJ J Am Coll Cardiol; 2013 Aug; 62(7):584-92. PubMed ID: 23665370 [TBL] [Abstract][Full Text] [Related]
48. Exercise programme to improve quality of life for patients with end-stage kidney disease receiving haemodialysis: the PEDAL RCT. Greenwood SA; Koufaki P; Macdonald JH; Bulley C; Bhandari S; Burton JO; Dasgupta I; Farrington K; Ford I; Kalra PA; Kumwenda M; Macdougall IC; Messow CM; Mitra S; Reid C; Smith AC; Taal MW; Thomson PC; Wheeler DC; White C; Yaqoob M; Mercer TH Health Technol Assess; 2021 Jun; 25(40):1-52. PubMed ID: 34156335 [TBL] [Abstract][Full Text] [Related]
49. Beta-blockers and inhibitors of the renin-angiotensin aldosterone system for chronic heart failure with preserved ejection fraction. Martin N; Manoharan K; Thomas J; Davies C; Lumbers RT Cochrane Database Syst Rev; 2018 Jun; 6(6):CD012721. PubMed ID: 29952095 [TBL] [Abstract][Full Text] [Related]
50. Quality of life in heart failure with preserved ejection fraction: importance of obesity, functional capacity, and physical inactivity. Reddy YNV; Rikhi A; Obokata M; Shah SJ; Lewis GD; AbouEzzedine OF; Dunlay S; McNulty S; Chakraborty H; Stevenson LW; Redfield MM; Borlaug BA Eur J Heart Fail; 2020 Jun; 22(6):1009-1018. PubMed ID: 32150314 [TBL] [Abstract][Full Text] [Related]
51. Multidisciplinary rehabilitation program in recently hospitalized patients with heart failure and preserved ejection fraction: rationale and design of a randomized controlled trial. Koifman E; Grossman E; Elis A; Dicker D; Koifman B; Mosseri M; Kuperstein R; Goldenberg I; Kamerman T; Levine-Tiefenbrun N; Klempfner R Am Heart J; 2014 Dec; 168(6):830-7.e1. PubMed ID: 25458645 [TBL] [Abstract][Full Text] [Related]
52. Effect of an exercise-based cardiac rehabilitation program "Baduanjin Eight-Silken-Movements with self-efficacy building" for heart failure (BESMILE-HF study): study protocol for a randomized controlled trial. Chen X; Jiang W; Lin X; Lundborg CS; Wen Z; Lu W; Marrone G Trials; 2018 Mar; 19(1):150. PubMed ID: 29490680 [TBL] [Abstract][Full Text] [Related]
53. Group cognitive rehabilitation to reduce the psychological impact of multiple sclerosis on quality of life: the CRAMMS RCT. Lincoln NB; Bradshaw LE; Constantinescu CS; Day F; Drummond AE; Fitzsimmons D; Harris S; Montgomery AA; das Nair R Health Technol Assess; 2020 Jan; 24(4):1-182. PubMed ID: 31934845 [TBL] [Abstract][Full Text] [Related]
54. Beta-blockers and inhibitors of the renin-angiotensin aldosterone system for chronic heart failure with preserved ejection fraction. Martin N; Manoharan K; Davies C; Lumbers RT Cochrane Database Syst Rev; 2021 May; 5(5):CD012721. PubMed ID: 34022072 [TBL] [Abstract][Full Text] [Related]
55. Addition of Supervised Exercise Training to a Post-Hospital Disease Management Program for Patients Recently Hospitalized With Acute Heart Failure: The EJECTION-HF Randomized Phase 4 Trial. Mudge AM; Denaro CP; Scott AC; Meyers D; Adsett JA; Mullins RW; Suna JM; Atherton JJ; Marwick TH; Scuffham P; O'Rourke P JACC Heart Fail; 2018 Feb; 6(2):143-152. PubMed ID: 29413370 [TBL] [Abstract][Full Text] [Related]
56. Carer administration of as-needed subcutaneous medication for breakthrough symptoms in people dying at home: the CARiAD feasibility RCT. Poolman M; Roberts J; Wright S; Hendry A; Goulden N; Holmes EA; Byrne A; Perkins P; Hoare Z; Nelson A; Hiscock J; Hughes D; O'Connor J; Foster B; Reymond L; Healy S; Lewis P; Wee B; Johnstone R; Roberts R; Parkinson A; Roberts S; Wilkinson C Health Technol Assess; 2020 May; 24(25):1-150. PubMed ID: 32484432 [TBL] [Abstract][Full Text] [Related]